Propionibacterium acnes: an update on its role in the pathogenesis of acne (Q34361098)

1 August 2017

Propionibacterium acnes: an update on its role in the pathogenesis of acne (English)

1 reference

1 August 2017

Propionibacterium acnes

object named as

Propionibacterium acnes

1 reference

C Beylot

1

1 reference

1 August 2017

N Auffret

2

1 reference

1 August 2017

F Poli

3

1 reference

1 August 2017

J-P Claudel

4

1 reference

1 August 2017

M-T Leccia

5

1 reference

1 August 2017

P Del Giudice

6

1 reference

1 August 2017

B Dreno

7

1 reference

1 August 2017

1 August 2013

1 reference

Journal of the European Academy of Dermatology and Venereology

1 August 2017

1 reference

1 August 2017

28

1 reference

1 August 2017

3

1 reference

1 August 2017

271-278

1 reference

The complete genome sequence of Propionibacterium acnes, a commensal of human skin

1 August 2017

1 reference

What's new in acne? An analysis of systematic reviews and clinically significant trials published in 2010-11.

21 January 2018

1 reference

Topographical and temporal diversity of the human skin microbiome

21 January 2018

1 reference

Insights in the pathogenic potential of Propionibacterium acnes from its complete genome

21 January 2018

1 reference

Variable expression of immunoreactive surface proteins of Propionibacterium acnes

21 January 2018

1 reference

New horizons for cutaneous microbiology: the role of biofilms in dermatological disease

21 January 2018

1 reference

Sampling and detection of skin Propionibacterium acnes: current status

21 January 2018

1 reference

Demodex folliculorum: requirements for understanding its role in human skin disease

21 January 2018

1 reference

The cutaneous microflora of adolescent, persistent and late-onset acne patients does not differ.

21 January 2018

1 reference

Propionibacterium acnes types I and II represent phylogenetically distinct groups

21 January 2018

1 reference

CAMP factor homologues in Propionibacterium acnes: a new protein family differentially expressed by types I and II.

21 January 2018

1 reference

Population genetic analysis of Propionibacterium acnes identifies a subpopulation and epidemic clones associated with acne

21 January 2018

1 reference

An expanded multilocus sequence typing scheme for propionibacterium acnes: investigation of 'pathogenic', 'commensal' and antibiotic resistant strains

21 January 2018

1 reference

Biofilm formation: a clinically relevant microbiological process

21 January 2018

1 reference

Expanding the microcomedone theory and acne therapeutics: Propionibacterium acnes biofilm produces biological glue that holds corneocytes together to form plug.

21 January 2018

1 reference

Biofilm formation by Propionibacterium acnes is associated with increased resistance to antimicrobial agents and increased production of putative virulence factors.

21 January 2018

1 reference

Review of the innate immune response in acne vulgaris: activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses

21 January 2018

1 reference

Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses

21 January 2018

1 reference

Distinct strains of Propionibacterium acnes induce selective human beta-defensin-2 and interleukin-8 expression in human keratinocytes through toll-like receptors

21 January 2018

1 reference

TLR9-dependent and independent pathways drive activation of the immune system by Propionibacterium acnes

21 January 2018

1 reference

Anti-inflammatory activity of cationic peptides: application to the treatment of acne vulgaris

21 January 2018

1 reference

Human beta-defensin-2 functions as a chemotactic agent for tumour necrosis factor-alpha-treated human neutrophils

21 January 2018

1 reference

Prostaglandin E(2) inhibits proteinase-activated receptor 2-signal transduction through regulation of receptor internalization

21 January 2018

1 reference

Protease-activated receptor-2 mediates the expression of inflammatory cytokines, antimicrobial peptides, and matrix metalloproteinases in keratinocytes in response to Propionibacterium acnes

21 January 2018

1 reference

Proinflammatory cytokine production by human keratinocytes stimulated with Propionibacterium acnes and P. acnes GroEL.

21 January 2018

1 reference

Induction of a chemoattractive proinflammatory cytokine response after stimulation of keratinocytes with Propionibacterium acnes and coproporphyrin III.

21 January 2018

1 reference

Effects of Propionibacterium acnes on various mRNA expression levels in normal human epidermal keratinocytes in vitro.

21 January 2018

1 reference

Heat-killed Propionibacterium acnes is capable of inducing inflammatory responses in skin

21 January 2018

1 reference

Increased interferon-gamma, interleukin-12p40 and IL-8 production in Propionibacterium acnes-treated peripheral blood mononuclear cells from patient with acne vulgaris: host response but not bacterial species is the determinant factor of the disease

21 January 2018

1 reference

Novel anti-acne actions of nadifloxacin and clindamycin that inhibit the production of sebum, prostaglandin E(2) and promatrix metalloproteinase-2 in hamster sebocytes.

21 January 2018

1 reference

Propionibacterium acnes stimulates pro-matrix metalloproteinase-2 expression through tumor necrosis factor-alpha in human dermal fibroblasts

21 January 2018

1 reference

Gene array expression profiling in acne lesions reveals marked upregulation of genes involved in inflammation and matrix remodeling

21 January 2018

1 reference

Complement C3 and immunoglobulin in inflammatory acne vulgaris

21 January 2018

1 reference

Differentiation of the sebaceous gland

21 January 2018

1 reference

Inflammatory events are involved in acne lesion initiation

21 January 2018

1 reference

Pro-inflammatory levels of interleukin-1 alpha-like bioactivity are present in the majority of open comedones in acne vulgaris.

21 January 2018

1 reference

Propionibacterium acnes activates the IGF-1/IGF-1R system in the epidermis and induces keratinocyte proliferation.

21 January 2018

1 reference

Insulin-like growth factor 1 receptor signaling regulates skin development and inhibits skin keratinocyte differentiation

21 January 2018

1 reference

Monoclonal antibody labeling for cytokeratins and filaggrin in the human pilosebaceous unit of normal, seborrhoeic and acne skin.

21 January 2018

1 reference

Involvement of Propionibacterium acnes in the augmentation of lipogenesis in hamster sebaceous glands in vivo and in vitro.

21 January 2018

1 reference

Corticotropin-releasing hormone: an autocrine hormone that promotes lipogenesis in human sebocytes

21 January 2018

1 reference

Involvement of the corticotropin-releasing hormone system in the pathogenesis of acne vulgaris

21 January 2018

1 reference

Cutaneous induction of corticotropin releasing hormone by Propionibacterium acnes extracts

21 January 2018

1 reference

Systemic isotretinoin therapy normalizes exaggerated TLR-2-mediated innate immune responses in acne patients

21 January 2018

1 reference

Nicotinamide inhibits Propionibacterium acnes-induced IL-8 production in keratinocytes through the NF-kappaB and MAPK pathways.

21 January 2018

1 reference

Skin microbiome: looking back to move forward.

21 January 2018

1 reference

Cathelicidin-BF, a snake cathelicidin-derived antimicrobial peptide, could be an excellent therapeutic agent for acne vulgaris

21 January 2018

1 reference

Antimicrobial and antifungal activities of a novel cationic antimicrobial peptide, omiganan, in experimental skin colonisation models

21 January 2018

1 reference

In vitro activities of three synthetic peptides derived from epinecidin-1 and an anti-lipopolysaccharide factor against Propionibacterium acnes, Candida albicans, and Trichomonas vaginalis.

21 January 2018

1 reference

Epigallocatechin-3-gallate improves acne in humans by modulating intracellular molecular targets and inhibiting P. acnes

21 January 2018

1 reference

Antibodies to P. acnes and P. acnes exocellular enzymes in the normal population at various ages and in patients with acne vulgaris

21 January 2018

1 reference

Vaccination targeting a surface sialidase of P. acnes: implication for new treatment of acne vulgaris

21 January 2018

1 reference

Propionibacterium acnes CAMP factor and host acid sphingomyelinase contribute to bacterial virulence: potential targets for inflammatory acne treatment

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JDV.12224

1 reference

1 August 2017

1 reference